Court OKs Luminex's Stock-Swap Acquisition of Tm BioScience | GenomeWeb
NEW YORK (GenomeWeb News) — An Ontario Superior Court of Justice has cleared the way for Luminex to acquire Tm Bioscience, Tm said yesterday.
Tm last week said that the deal could close within a day of the court’s favorable decision.
As GenomeWeb News reported in December, the deal would exchange one Tm share for every .06 share of Luminex. Luminex said at the time that would be roughly a 41.5 percent premium for Tm’s shareholders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.